admin

In 2020, pharma companies pivoted from slow and painstaking processes to speed and agility that developed life-saving vaccines and treatments in less than a year.

Over the last week, we analyzed the top five emerging trends facing CFOs in 2022 and beyond.

The third trend in our ongoing series, “The Top Trends for CFOs in a Post Pandemic World,” showed us that various government regulations often require the use of digitization.

In our ongoing blog series, “The Top Trends for CFO’s in a Post Pandemic World,” we have discussed a variety of topics including harnessing real-time data to drive strategy.

The first part in our ongoing blog series, “The Top Trends for CFO’s in a Post-Pandemic World” looked at how crucial having access to real-time data is.

In this blog series, we will analyze the top five emerging trends facing CFO’s in 2022 and beyond.

Improving Drug Development Speed with AI in Life Sciences – with Emmanuel Walckenaer of YSEOP and  Dan Faggella from Emerj.

With Salesforce’s acquisition of Narrative Science, any company not utilizing integrations related to Tableau will need to find a new vendor in the upcoming months. 

With Yseop’s new Augmented Analyst release, we have made it easier than ever for customers to create and maintain their NLG data and reporting processes across life sciences and financial services.